Page 56 - MI-1-1
P. 56

Microbes & Immunity                                                  The feature of bladder cancer stem cells



                 single-cell analysis reveals the crosstalk between cancer-     doi: 10.1016/j.cbpa.2023.102362
                 associated fibroblasts and tumor microenvironment. Mol   147.  Yu  L,  Li  Z,  Mei  H,  et al.  Patient-derived  organoids  of
                 Cancer. 2023;22(1):170.
                                                                    bladder cancer recapitulate antigen expression profiles
                 doi: 10.1186/s12943-023-01876-x                    and serve as a personal evaluation model for CAR-T cells
                                                                    in vitro. Clin Transl Immunology. 2021;10(2):e1248.
            142.  Chung WM, Molony RD, Lee YF. Non-stem bladder
                 cancer cell-derived extracellular vesicles promote cancer      doi: 10.1002/cti2.1248
                 stem cell survival in response to chemotherapy. Stem Cell   148.  Parriott G, Deal K, Crean S, Richardson E, Nylen E,
                 Res Ther. 2021;12(1):533.
                                                                    Barber A. T-cells expressing a chimeric-PD1-Dap10-
                 doi: 10.1186/s13287-021-02600-6                    CD3zeta receptor reduce tumour burden in multiple
                                                                    murine syngeneic models of solid cancer.  Immunology.
            143.  Andreucci E, Peppicelli S, Ruzzolini J,  et al. The acidic
                 tumor microenvironment drives a stem-like phenotype in   2020;160(3):280-294.
                 melanoma cells. J Mol Med (Berl). 2020;98(10):1431-1446.     doi: 10.1111/imm.13187
                 doi: 10.1007/s00109-020-01959-y               149.  Miyata H, Hirohashi Y, Yamada S, et al. GRIK2 is a target for
                                                                    bladder cancer stem-like cell-targeting immunotherapy.
            144.  Ramadan WS, Alkarim S, Moulay M, et al. Modulation of
                 the tumor microenvironment by ellagic acid in rat model for   Cancer Immunol Immunother. 2022;71(4):795-806.
                 hepatocellular carcinoma: A potential target against hepatic      doi: 10.1007/s00262-021-03025-z
                 cancer stem cells. Cancers (Basel). 2023;15(19):4891.
                                                               150.  O’Brien KA, Murray AJ, Simonson TS. Notch signaling
                 doi: 10.3390/cancers15194891                       and cross-talk in hypoxia: A candidate pathway for high-
                                                                    altitude adaptation. Life (Basel). 2022;12(3):437.
            145.  Wang G, Heijs B, Kostidis S, et al. Spatial dynamic metabolomics
                 identifies metabolic cell fate trajectories in human kidney      doi: 10.3390/life12030437
                 differentiation. Cell Stem Cell. 2022;29(11):1580-1593.e7.
                                                               151.  Noorbakhsh N, Hayatmoghadam B, Jamali M,
                 doi: 10.1016/j.stem.2022.10.008                    Golmohammadi M, Kavianpour M. The Hippo signaling
                                                                    pathway  in  leukemia:  Function,  interaction,  and
            146.  Planque M, Igelmann S, Ferreira Campos AM, Fendt SM.
                 Spatial metabolomics principles and application to cancer   carcinogenesis. Cancer Cell Int. 2021;21(1):705.
                 research. Curr Opin Chem Biol. 2023;76:102362.     doi: 10.1186/s12935-021-02408-7








































            Volume 1 Issue 1 (2024)                         50                               doi: 10.36922/mi.2377
   51   52   53   54   55   56   57   58   59   60   61